The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romani, L.
Right arrow Articles by Bistoni, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romani, L.
Right arrow Articles by Bistoni, F.

The Journal of Immunology, Vol 150, Issue 3 925-931, Copyright © 1993 by American Association of Immunologists

ARTICLES

CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance

L Romani, A Mencacci, E Cenci, R Spaccapelo, P Mosci, P Puccetti and F Bistoni
Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Italy.

Previous work has shown that in hybrid (BALB/cCr x DBA/2Cr)F1 mice the development of a fatal disseminated disease by systemic infection with virulent Candida albicans is associated with the detection of strong Th2-like responses. However, a predominant Th1-like response and long- lived antifungal protection are induced by vaccinating these mice with live blastospores of attenuated C. albicans strains. When injected into DBA/2Cr mice, one such live vaccine strain was found in the present study to result in a progressive disease characterized by strong Th2 responses. Elevated serum IgG1, IgA, and IgE responses, weak or absent footpad reactions, sustained production in vitro of Th2 (IL-4 and IL- 10) but not Th1 (IL-2 and IFN-gamma) cytokines by CD4+ cells, and eosinophilia were all detected in DBA/2 mice after infection with the attenuated vaccine. This was in marked contrast with the development of strong Th1 responses and persistent anticandidal protection in similarly infected, H-2-compatible BALB/cCr mice. Therefore, our data suggest that the type of Th response that predominates in mice after C. albicans infection correlates with genetically determined susceptibility or vaccine-induced resistance. Moreover, the genetic control of this resistance may not be associated with the H-2 complex.


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
C.-F. Kuo, Y.-H. Wang, H.-Y. Lei, C.-H. Wang, and N. Tsao
Concanavalin A Protects Mice from a Lethal Inoculation of Intragastric Klebsiella pneumoniae and Reduces the Induced Liver Damage
Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3122 - 3130.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. M. LeBlanc, M. M. Barousse, and P. L. Fidel Jr.
Role for Dendritic Cells in Immunoregulation during Experimental Vaginal Candidiasis.
Infect. Immun., June 1, 2006; 74(6): 3213 - 3221.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Agostini, E. Cenci, E. Pericolini, G. Nocentini, G. Bistoni, A. Vecchiarelli, and C. Riccardi
The Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Gene Modulates the Response to Candida albicans Infection
Infect. Immun., November 1, 2005; 73(11): 7502 - 7508.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
Y. Zafirova, M. Yordanov, and R. Kalfin
Antiarthritic effect of VIP in relation to the host resistance against Candida albicans infection
Int. Immunol., August 1, 2004; 16(8): 1125 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
N. Tang, L. Liu, K. Kang, P. K. Mukherjee, M. Takahara, G. Chen, T. S. McCormick, K. D. Cooper, and M. Ghannoum
Inhibition of Monocytic Interleukin-12 Production by Candida albicans via Selective Activation of ERK Mitogen-Activated Protein Kinase
Infect. Immun., May 1, 2004; 72(5): 2513 - 2520.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. L. Wozniak, F. L. Wormley Jr., and P. L. Fidel Jr.
Candida-Specific Antibodies during Experimental Vaginal Candidiasis in Mice
Infect. Immun., October 1, 2002; 70(10): 5790 - 5799.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Bacci, C. Montagnoli, K. Perruccio, S. Bozza, R. Gaziano, L. Pitzurra, A. Velardi, C. F. d'Ostiani, J. E. Cutler, and L. Romani
Dendritic Cells Pulsed with Fungal RNA Induce Protective Immunity to Candida albicans in Hematopoietic Transplantation
J. Immunol., March 15, 2002; 168(6): 2904 - 2913.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. L. Newman and A. Holly
Candida albicans Is Phagocytosed, Killed, and Processed for Antigen Presentation by Human Dendritic Cells
Infect. Immun., November 1, 2001; 69(11): 6813 - 6822.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
F. L. Wormley Jr., J. Chaiban, and P. L. Fidel Jr.
Cell Adhesion Molecule and Lymphocyte Activation Marker Expression during Experimental Vaginal Candidiasis
Infect. Immun., August 1, 2001; 69(8): 5072 - 5079.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Mencacci, K. Perruccio, A. Bacci, E. Cenci, R. Benedetti, M. F. Martelli, F. Bistoni, R. Coffman, A. Velardi, and L. Romani
Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists
Blood, March 1, 2001; 97(5): 1483 - 1490.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Mizutani, M. Endo, T. Ino-ue, M. Kurasawa, Y. Uno, H. Saito, K. Onogi, I. Kato, and K. Takesako
CD4+-T-Cell-Mediated Resistance to Systemic Murine Candidiasis Induced by a Membrane Fraction of Candida albicans
Antimicrob. Agents Chemother., October 1, 2000; 44(10): 2653 - 2658.
[Abstract] [Full Text]

Home page
 Infect. Immun.Home page
P. Chiani, C. Bromuro, and A. Torosantucci
Defective Induction of Interleukin-12 in Human Monocytes by Germ-Tube Forms of Candida albicans
Infect. Immun., October 1, 2000; 68(10): 5628 - 5634.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Elahi, G. Pang, R. Clancy, and R. B. Ashman
Cellular and Cytokine Correlates of Mucosal Protection in Murine Model of Oral Candidiasis
Infect. Immun., October 1, 2000; 68(10): 5771 - 5777.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Mencacci, A. Bacci, E. Cenci, C. Montagnoli, S. Fiorucci, A. Casagrande, R. A. Flavell, F. Bistoni, and L. Romani
Interleukin 18 Restores Defective Th1 Immunity to Candida albicans in Caspase 1-Deficient Mice
Infect. Immun., September 1, 2000; 68(9): 5126 - 5131.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
J. Xiong, K. Kang, L. Liu, Y. Yoshida, K. D. Cooper, and M. A. Ghannoum
Candida albicans and Candida krusei Differentially Induce Human Blood Mononuclear Cell Interleukin-12 and Gamma Interferon Production
Infect. Immun., May 1, 2000; 68(5): 2464 - 2469.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
P. L. Fidel Jr., W. Luo, C. Steele, J. Chabain, M. Baker, and F. Wormley Jr.
Analysis of Vaginal Cell Populations during Experimental Vaginal Candidiasis
Infect. Immun., June 1, 1999; 67(6): 3135 - 3140.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. Vazquez-Torres, J. Jones-Carson, R. D. Wagner, T. Warner, and E. Balish
Early Resistance of Interleukin-10 Knockout Mice to Acute Systemic Candidiasis
Infect. Immun., February 1, 1999; 67(2): 670 - 674.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Mencacci, E. Cenci, G. D. Sero, C. Fe d'Ostiani, P. Mosci, G. Trinchieri, L. Adorini, and L. Romani
IL-10 Is Required for Development of Protective Th1 Responses in IL-12-Deficient Mice upon Candida albicans Infection
J. Immunol., December 1, 1998; 161(11): 6228 - 6237.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Cenci, A. Mencacci, G. Del Sero, C. Fe d'Ostiani, P. Mosci, A. Bacci, C. Montagnoli, M. Kopf, and L. Romani
IFN-{gamma} Is Required for IL-12 Responsiveness in Mice with Candida albicans Infection
J. Immunol., October 1, 1998; 161(7): 3543 - 3550.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
A. A. Gaspari, R. Burns, A. Nasir, D. Ramirez, R. K. Barth, and C. G. Haidaris
CD86 (B7-2), but Not CD80 (B7-1), Expression in the Epidermis of Transgenic Mice Enhances the Immunogenicity of Primary Cutaneous Candida albicans Infections
Infect. Immun., September 1, 1998; 66(9): 4440 - 4449.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
G. P. Bembridge, J. A. Lopez, R. Cook, J. A. Melero, and G. Taylor
Recombinant Vaccinia Virus Coexpressing the F Protein of Respiratory Syncytial Virus (RSV) and Interleukin-4 (IL-4) Does Not Inhibit the Development of RSV-Specific Memory Cytotoxic T Lymphocytes, whereas Priming Is Diminished in the Presence of High Levels of IL-2 or Gamma Interferon
J. Virol., May 1, 1998; 72(5): 4080 - 4087.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Southwood, J. Sidney, A. Kondo, M.-F. del Guercio, E. Appella, S. Hoffman, R. T. Kubo, R. W. Chesnut, H. M. Grey, and A. Sette
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
J. Immunol., April 1, 1998; 160(7): 3363 - 3373.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. Mencacci, G. Del Sero, E. Cenci, C. F. d'Ostiani, A. Bacci, C. Montagnoli, M. Kopf, and L. Romani
Endogenous Interleukin 4 Is Required for Development of Protective CD4+ T Helper Type 1 Cell Responses to Candida albicans
J. Exp. Med., February 2, 1998; 187(3): 307 - 317.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. M. Lavigne, L. R. Schopf, C. L. Chung, R. Maylor, and J. P. Sypek
The Role of Recombinant Murine IL-12 and IFN-{gamma} in the Pathogenesis of a Murine Systemic Candida albicans Infection
J. Immunol., January 1, 1998; 160(1): 284 - 292.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.